Subscribe to RSS
DOI: 10.1055/s-0045-1812097
Large-bore Thrombectomy for Iliocaval Thrombosis: An Updated Device Review
Authors
Abstract
Large-bore thrombectomy has emerged as a critical treatment option in the management of iliocaval thrombosis, a condition associated with high morbidity and mortality. These devices are designed for rapid removal of clot and symptom resolution while minimizing the need for thrombolytic therapy. Ongoing trials, prospective registries, and retrospective reviews are also investigating the role of early thrombectomy or thrombolysis on subsequent development of post-thrombotic syndrome. These interventions are particularly beneficial for patients with contraindications to systemic or catheter-directed thrombolysis, those at high risk for post-thrombotic syndrome, or those with chronic thrombus, which is less likely to respond to lytic therapy.
These devices utilize mechanical, aspiration, and rotatory systems to break up and remove acute and chronic, densely adherent thrombus. Each has unique characteristics that make them preferred in different disease states and many cases require use of multiple devices in conjunction with one another. This review describes the importance of large-bore thrombectomy in the treatment of iliocaval thromboembolic disease and highlights modern devices and case-specific uses for each.
Keywords
thrombosis - large-bore thrombectomy - iliocaval thromboembolism - aspiration thrombectomy - mechanical thrombectomy - interventional radiologyPublication History
Article published online:
03 November 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Kahn SR, Shbaklo H, Lamping DL. et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6 (07) 1105-1112
- 2 Enden T, Haig Y, Kløw NE. et al; CaVenT Study Group. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379 (9810) 31-38
- 3 Notten P, Ten Cate-Hoek AJ, Arnoldussen CWKP. et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol 2020; 7 (01) e40-e49
- 4 Vedantham S, Goldhaber SZ, Julian JA. et al; ATTRACT Trial Investigators. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377 (23) 2240-2252
- 5 Dexter D, Kado H, Shaikh A. et al. Safety and effectiveness of mechanical thrombectomy from the fully enrolled multicenter, prospective CLOUT registry. J Soc Cardiovasc Angiogr Interv 2023; 2 (02) 100585
- 6 Shaikh A, Zybulewski A, Paulisin J. et al; CLOUT Investigators. Six-month outcomes of mechanical thrombectomy for treating deep vein thrombosis: analysis from the 500-patient CLOUT registry. Cardiovasc Intervent Radiol 2023; 46 (11) 1571-1580
- 7 BOLT: A prospective, multicenter study of patients with deep vein thrombosis to evaluate the safety and efficacy of the Indigo® Aspiration System. 2021 https://clinicaltrials.gov/study/NCT05003843
- 8 Abramowitz SD. et al. Rationale and design of the DEFIANCE study: a randomized controlled trial of mechanical thrombectomy versus anticoagulation alone for iliofemoral deep vein thrombosis. Am Heart J 2025; 281: 92-102
- 9 Abramowitz SD, Kado H, Schor J. et al; CLOUT Investigators. Six-month deep vein thrombosis outcomes by chronicity: analysis of the real-world ClotTriever Outcomes Registry. J Vasc Interv Radiol 2023; 34 (05) 879-887.e4
- 10 Hofmann LR, Gagne P, Brown JA, Saunders A, Comerota A. VIVO Study Investigators. Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study). J Vasc Surg Venous Lymphat Disord 2023; 11 (03) 532-541.e4
- 11 Razavi MK, Black S, Gagne P, Chiacchierini R, Nicolini P, Marston W. VIRTUS Investigators. Pivotal study of endovenous stent placement for symptomatic iliofemoral venous obstruction. Circ Cardiovasc Interv 2019; 12 (12) e008268
- 12 Murphy E, Gibson K, Sapoval M. et al. Pivotal study evaluating the safety and effectiveness of the Abre venous self-expanding stent system in patients with symptomatic iliofemoral venous outflow obstruction. Circ Cardiovasc Interv 2022; 15 (02) e010960
- 13 Dake MD, O'Sullivan G, Shammas NW, Lichtenberg M, Mwipatayi BP, Settlage RA. VERNACULAR Trial Investigators. Three-year results from the Venovo venous stent study for the treatment of iliac and femoral vein obstruction. Cardiovasc Intervent Radiol 2021; 44 (12) 1918-1929
- 14 Chen JX, Sudheendra D, Stavropoulos SW, Nadolski GJ. Role of catheter-directed thrombolysis in management of iliofemoral deep venous thrombosis. Radiographics 2016; 36 (05) 1565-1575
- 15 Shah NG, Wible BC, Paulisin JA. et al. Management of inferior vena cava thrombosis with the FlowTriever and ClotTriever systems. J Vasc Surg Venous Lymphat Disord 2021; 9 (03) 615-620
- 16 Monroe EJ, Woods MA, Shin DS. et al. Percutaneous treatment of symptomatic deep vein thrombosis in adolescents using large-bore thrombectomy systems. Pediatr Radiol 2023; 53 (13) 2692-2698
- 17 Maldonado TS, Dexter DJ, Kado H. et al; CLOUT Registry Investigators. Outcomes from the ClotTriever Outcomes Registry show symptom duration may underestimate deep vein thrombus chronicity. J Vasc Surg Venous Lymphat Disord 2022; 10 (06) 1251-1259
- 18 Dexter DJ, Kado H, Schor J. et al; CLOUT Investigators. Interim outcomes of mechanical thrombectomy for deep vein thrombosis from the All-Comer CLOUT Registry. J Vasc Surg Venous Lymphat Disord 2022; 10 (04) 832-840.e2
- 19 Droz N, Jammeh ML, Khetarpaul V. Percutaneous thrombectomy of filter-associated inferior vena cava occlusion. Ann Vasc Surg Brief Rep Innov 2022; 2 (02) 100076
- 20 Jolly MA, Lockhart MM, Shah D. et al. Outcomes from a tertiary care center using a catheter thrombectomy system for managing acute iliofemoral deep vein thrombosis. J Vasc Surg Venous Lymphat Disord 2022; 10 (05) 1044-1050
- 21 Shaikh A. Mechanical thrombectomy of venous in-stent thrombosis with the novel RevCore thrombectomy system: a report of 2 cases. Radiol Case Rep 2023; 19 (02) 576-580
- 22 Montoya C, Polania-Sandoval C, Almeida JI. Endovascular mechanical thrombectomy of iliofemoral venous stent occlusion with the novel RevCore thrombectomy system: case reports and literature review. J Vasc Surg Cases Innov Tech 2024; 10 (03) 101432
- 23 Solano A, Klein A, Gonzalez-Guardiola G. et al. RevCore thrombectomy system for treatment of chronic left external and common iliac vein stent occlusion. J Vasc Surg Cases Innov Tech 2024; 10 (03) 101482
- 24 Lopez R, DeMartino R, Fleming M, Bjarnason H, Neisen M. Aspiration thrombectomy for acute iliofemoral or central deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 2019; 7 (02) 162-168
- 25 Huasen B. et al. Initial experience of aspiration thrombectomy using the Indigo aspiration system for acute iliofemoral deep vein thrombosis. J Clin Case Stud 2021; 1: 1-6
- 26 Robertson B, Neville E, Muck A. et al. Technical success and short-term results from mechanical thrombectomy for lower extremity iliofemoral deep vein thrombosis using a computer aided mechanical aspiration thrombectomy device. J Vasc Surg Venous Lymphat Disord 2022; 10 (03) 594-601
- 27 Rajput FA, Du L, Woods M, Jacobson K. Percutaneous vacuum-assisted thrombectomy using AngioVac aspiration system. Cardiovasc Revasc Med 2020; 21 (04) 489-493
- 28 Moriarty JM, Rueda V, Liao M. et al. Endovascular removal of thrombus and right heart masses using the AngioVac system: results of 234 patients from the prospective, multicenter Registry of AngioVac Procedures in Detail (RAPID). J Vasc Interv Radiol 2021; 32 (04) 549-557.e3
- 29 Rodoplu O, Yildiz CE, Oztas DM. et al. The efficacy of rotational pharmaco-mechanical thrombectomy in patients with acute iliofemoral deep vein thrombosis: Is the standard treatment of deep vein thrombosis changing?. Phlebology 2021; 36 (02) 119-126
- 30 Bozkurt A, Kırbaş İ, Kösehan D, Demirçelik B, Nazlı Y. Pharmacomechanical thrombectomy in the management of deep vein thrombosis using the cleaner device: an initial single-center experience. Ann Vasc Surg 2015; 29 (04) 670-674
- 31 Greenberg C, Shin DS, Verst L. et al. Protrieve sheath embolic protection during venous thrombectomy: early experience in seventeen patients. CVIR Endovasc 2024; 7 (01) 74
- 32 Goronzy IN, Yearwood A, Drews E, Brundage T, Ranade M, Moriarty JM. Endovascular thrombectomy provides durable, symptomatic relief in iliocaval tumor thrombosis. Clin Radiol 2024; 79 (10) e1268-e1278
- 33 Moriarty JM, Liao M, Kim GHJ. et al. Procedural outcomes associated with use of the AngioVac System for right heart thrombi: a safety report from RAPID registry data. Vasc Med 2022; 27 (03) 277-282
- 34 Mathevosian S, Ranade M. Right heart clot-in-transit: endovascular therapies. Semin Intervent Radiol 2022; 39 (05) 515-522
- 35 Verma I, Chang EY, Kumar G, Sachdeva R. Catheter directed embolectomy of right atrial clot in transit—a case series. Catheter Cardiovasc Interv 2021; 97 (05) 869-873
- 36 Gong M, Fu G, Liu Z. et al. Rheolytic thrombectomy using an AngioJet ZelanteDVT catheter or a Solent Omni catheter for patients with proximal vein thrombosis. Thromb J 2023; 21 (01) 25

